Participants at the 2010 International Medical Device Industry Compliance Conference examined this hot issue from all angles, reports Karen Finn.
Medtech companies are aware that they need to increase their focus on compliance at home and abroad. However, they are still grappling with how to go about implementing an effective international compliance programme that reconciles the US government’s crackdown on foreign bribery, its new legal requirements for disclosing industry-physician financial relationships, industry codes of conduct and corporate policies...
Please Login to read the full article.
